Related Experiment Video
Updated: Aug 16, 2026

Identification of Rare Bacterial Pathogens by 16S rRNA Gene Sequencing and MALDI-TOF MS
Published on: July 11, 2016
Molecular and phenotypic features for identification of the opportunistic pathogens Ochrobactrum spp
Corinne Teyssier1, Hélène Marchandin1, Hélène Jean-Pierre1
1Laboratoire de bactériologie, faculté de pharmacie, 15, avenue Charles Flahault, 34093 Montpellier Cedex 5, France 2Laboratoire de bactériologie, hôpital Arnaud de Villeneuve, 34295 Montpellier Cedex 5, France 3Laboratoire de bactériologie, hôpital Carremeau, 30060 îmes, France.
Abstract:
Among the six species characterized within the genus Ochrobactrum, Ochrobactrum anthropi and Ochrobactrum intermedium are currently reported as opportunistic pathogens in humans. Since the species identification is mainly based on 16S rDNA analysis, the aim of this study was to search for other characteristics useful for Ochrobactrum species discrimination. Ribotyping, morphological and biochemical analyses, and antimicrobial susceptibility testing were performed for a panel of 35 clinical isolates, first identified to the species level using 16S rDNA sequencing. Type and reference strains of five Ochrobactrum species were comparatively analysed. Commercial identification systems such as API 20NE and VITEK 2 were tested for their ability to identify Ochrobactrum anthropi and to detect other members of the genus Ochrobactrum. An improved protocol for the identification of Ochrobactrum spp. by routine medical microbiology practices is proposed: isolation of a non-fastidious non-fermenting oxidase-positive Gram-negative rod resistant to all beta-lactams except imipenem indicates the genus Ochrobactrum, and the API 20NE system confirms the genus identification for most strains, whereas the VITEK 2 system using ID-GNB cards was less powerful. Urease activity, the mucoidy of the colonies, growth at 45 degrees C on tryptic soy agar, and susceptibility to colistin, tobramycin and netilmicin should be considered as differential characteristics for identification of O. anthropi and O. intermedium to the species level. However, definitive identification depends on genotyping methods.
Insights
Accurate identification of Ochrobactrum species, including opportunistic pathogens Ochrobactrum anthropi and Ochrobactrum intermedium, requires more than 16S rDNA analysis. This study proposes improved methods for clinical microbiology practices.
Area of Science:
- Medical Microbiology
- Bacterial Taxonomy
- Clinical Diagnostics
Background:
- The genus Ochrobactrum includes species like Ochrobactrum anthropi and Ochrobactrum intermedium, recognized as opportunistic human pathogens.
- Current species identification primarily relies on 16S ribosomal DNA (rDNA) sequencing, necessitating complementary methods for robust discrimination.
Purpose of the Study:
- To identify additional characteristics beyond 16S rDNA analysis for accurate Ochrobactrum species differentiation.
- To evaluate the efficacy of commercial identification systems (API 20NE, VITEK 2) for Ochrobactrum identification.
- To propose an improved protocol for routine medical microbiology identification of Ochrobactrum species.
Main Methods:
- Analysis of 35 clinical isolates and type/reference strains of five Ochrobactrum species.
- Utilized ribotyping, morphological and biochemical analyses, and antimicrobial susceptibility testing.
- Assessed performance of API 20NE and VITEK 2 identification systems.
Main Results:
- An initial identification protocol involves isolating non-fastidious, non-fermenting, oxidase-positive Gram-negative rods resistant to most beta-lactams (except imipenem) to indicate the Ochrobactrum genus.
- API 20NE system demonstrated effectiveness in confirming genus identification for most strains.
- Urease activity, colony mucoidy, growth at 45°C, and susceptibility to colistin, tobramycin, and netilmicin are key differential characteristics for O. anthropi and O. intermedium.
- VITEK 2 system with ID-GNB cards showed limited power for Ochrobactrum identification.
Conclusions:
- Routine medical microbiology can be enhanced for Ochrobactrum identification using a combination of phenotypic characteristics and commercial systems.
- While phenotypic markers aid species-level differentiation, definitive identification of Ochrobactrum species ultimately relies on genotypic methods.
- The proposed protocol offers a practical approach to improve the identification accuracy of Ochrobactrum species in clinical settings.
Related Concept Videos
Rapid Identification of Pathogens
Methods of Classification and Identification
Bacterial Phylum Actinobacteria
Applications of Molecular Taxonomy
Modern Molecular Taxonomy
Fungal Group Zygomycota

